SCHEMBL9811010

SCHEMBL9811010

O=C1c2cc(F)ccc2-c2cc(F)ccc21

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
CA7 P43166 1/20 0.48
CA9 Q16790 1/20 0.48
ALDH1A1 P00352 3/20 0.47
CYP3A4 P08684 3/20 0.47
CYP1A2 P05177 2/20 0.47
ESR1 P03372 1/20 0.46
MAOA P21397 1/20 0.46
UGT1A1 P22309 1/20 0.46
MAOB P27338 1/20 0.46
ESR2 Q92731 1/20 0.46
USP8 P40818 2/20 0.46
USP7 Q93009 2/20 0.46
USP47 Q96K76 1/20 0.46
PTPN1 P18031 2/20 0.44
PTPRC P08575 2/20 0.44
MAPT P10636 1/20 0.41
TP53 P04637 2/20 0.41
MAPK1 P28482 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9328908 0.95 CA1 (0.52) CA1CA2CA7CA9ALDH1A1
SCHEMBL4322090 0.95 CA1 (0.52) CA1CA2CA7CA9ALDH1A1
SCHEMBL30479662 0.95 CA1 (0.52) CA1CA2CA7CA9ALDH1A1
SCHEMBL7432075 0.95 CA1 (0.52) CA1CA2CA7CA9ALDH1A1
SCHEMBL563010 0.91 MEN1 (0.55) ALDH1A1CYP3A4CYP1A2MAOAMAOB
SCHEMBL181722 0.91 PTPRC (0.55) ALDH1A1CYP3A4CYP1A2MAOAMAOB
SCHEMBL29390818 0.91 PTPRC (0.55) ALDH1A1CYP3A4CYP1A2MAOAMAOB
SCHEMBL13487415 0.90 CA1 (0.52) CA1CA2CA7CA9ALDH1A1
SCHEMBL3894758 0.88 MEN1 (0.57) CA1CA2CA7CA9ALDH1A1
SCHEMBL30886642 0.86 PTPRC (0.60) ALDH1A1CYP3A4MAOAPTPN1PTPRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0092385-B1 HYDANTOIN DERIVATIVES FOR USE IN INHIBITING ALDOSE REDUCTASE ACTIVITY, COMPOSITIONS THEREFOR AND PROCESS FOR PREPARING SPIRO-FLUOREN COMPOUNDS ALCON LABORATORIES, INC. (US) 1991-06-12 EP disclosed
US-4540700-A Treatment of diabetic complications with certain spiro-imidazolidine-diones ALCON LABORATORIES, INC. (US) 1985-09-10 US disclosed
US-4438272-A COMPLICATIONS OF DIABETES ALCON LABORATORIES, INC. (US) 1984-03-20 US disclosed
US-4436745-A TETRACYCLIC SPIROHYDANTOINS ALCON LABORATORIES, INC. (US) 1984-03-13 US disclosed
WO-1983003543-A1 METHOD OF INHIBITING ALDOSE REDUCTASE ACTIVITY, COMPOSITIONS THEREFOR AND PROCESS FOR PREPARING SPIRO-FLUOROFLUOREN AND SPIRO-DIFLUOROFLUOREN COMPOUNDS ALCON LAB INC (US) 1983-10-27 WO disclosed
EP-0092385-A2 Hydantoin derivatives for use in inhibiting aldose reductase activity, compositions therefor and process for preparing spiro-fluoren compounds ALCON LABORATORIES, INC. (US) 1983-10-26 EP disclosed